Axoft to Begin Brain Implant Clinical Study
Press Release
Transformative solutions have been shown in medicines, health and disease monitoring, and in our food systems. Increasing the applications and the access of these transformative solutions drives our companies as the companies converge biology, materials, engineering, and AI to empower a healthy, vibrant world.
“The Engine lives and breathes the principles around the convergence of different disciplines, and that makes it special. Not only do they have industry-leading expertise in biotech and pharma, they also bring impressive background in software and hardware. Cellino exists at the interface of all of these specialties, and we’ve benefited greatly from having an investor like Engine Ventures who speaks all of these languages.”
Nahiba Saklayen Cellino ![]()
Curing the world’s toughest diseases by automating personalized medicine.
Decoding the brain’s biology to cure neurological diseases.
Unlocking better therapies through blood-based diagnosis and monitoring of complex diseases.
Harnessing a novel bio-analyte to transform patient care.
Transforming cancer therapy by targeting the extracellular matrix.
Making our food system more resilient.
Enabling precision-genomic editing with single-stranded DNA technology.
Unlocking the immune system to fight cancer and disease.
Building implantable electronics as soft as the brain to amplify brain-machine communication.
Breakthrough mitochondrial-based therapies for neurological diseases.
Generating diverse genomes to scale and digitalize biomanufacturing.
Repurposing wastewater into low-cost feedstock to enable biomanufacturing at scale.
Protecting and restoring natural ecosystems, one plant cell at a time.
Data analysis that will transform wastewater infrastructure into public health observatories.
The future of sustainable skincare.
Using wireless charging to unlock new opportunities in mobility and medicine.
Ultrasound drug delivery for difficult-to-treat diseases.
Unlocking better therapies through blood-based diagnosis and monitoring of complex diseases.
Rapid robotic synthesis of valuable peptides and protein structures that can’t be manufactured with cells.
Generating diverse genomes to scale and digitalize biomanufacturing.
Decoding the brain’s biology to cure neurological diseases.
Transforming cancer therapy by targeting the extracellular matrix.
Harnessing a novel bio-analyte to transform patient care.
Enabling precision-genomic editing with single-stranded DNA technology.
Repurposing wastewater into low-cost feedstock to enable biomanufacturing at scale.
Protecting and restoring natural ecosystems, one plant cell at a time.
Using wireless charging to unlock new opportunities in mobility and medicine.
Building implantable electronics as soft as the brain to amplify brain-machine communication.
Data analysis that will transform wastewater infrastructure into public health observatories.
The future of sustainable skincare.
Breakthrough mitochondrial-based therapies for neurological diseases.
Unlocking the immune system to fight cancer and disease.
Making our food system more resilient.
Curing the world’s toughest diseases by automating personalized medicine.
Cellular engineering, at unparalleled speeds, from discovery to the clinic.
Ultrasound drug delivery for difficult-to-treat diseases.